OTCPK:CYBQ.F

Stock Analysis Report

Executive Summary

CYBERDYNE Inc. manufactures and sells medical devices in Japan and internationally.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.

Risks

  • CYBERDYNE is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has CYBERDYNE's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.2%

OTCPK:CYBQ.F

-0.9%

US Medical Equipment

1.3%

US Market


1 Year Return

-11.2%

OTCPK:CYBQ.F

9.1%

US Medical Equipment

2.0%

US Market

CYBQ.F underperformed the Medical Equipment industry which returned 8.7% over the past year.

CYBQ.F underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

CYBQ.FIndustryMarket
7 Day3.2%-0.9%1.3%
30 Day11.5%0.7%3.9%
90 Day14.6%4.4%3.4%
1 Year-11.2%-11.2%10.0%9.1%4.2%2.0%
3 Yearn/a70.7%65.5%47.2%37.6%
5 Yearn/a130.7%104.3%60.5%42.9%

Price Volatility Vs. Market

How volatile is CYBERDYNE's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CYBERDYNE undervalued based on future cash flows and its price relative to the stock market?

3.2x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for CYBERDYNE to establish if it is available at moderate discount.

Unable to calculate intrinsic value for CYBERDYNE to establish if it is available at substantial discount.


Price Based on Earnings

CYBERDYNE is loss making, we can't compare its value to the US Medical Equipment industry average.

CYBERDYNE is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for CYBERDYNE, we can't assess if its growth is good value.


Price Based on Value of Assets

CYBERDYNE is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is CYBERDYNE expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

72.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

CYBERDYNE's revenue is expected to grow significantly at over 20% yearly.

CYBERDYNE's earnings are expected to grow significantly at over 20% yearly.

CYBERDYNE's revenue growth is expected to exceed the United States of America market average.

CYBERDYNE's earnings growth is expected to exceed the United States of America market average.

CYBERDYNE's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

CYBERDYNE is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has CYBERDYNE performed over the past 5 years?

16.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

CYBERDYNE does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare CYBERDYNE's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare CYBERDYNE's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if CYBERDYNE has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if CYBERDYNE has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if CYBERDYNE improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is CYBERDYNE's financial position?


Financial Position Analysis

CYBERDYNE is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

CYBERDYNE's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

CYBERDYNE has no debt.

CYBERDYNE has no debt compared to 5 years ago when it was 49.8%.


Balance Sheet

High level of physical assets or inventory.

CYBERDYNE has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

CYBERDYNE has sufficient cash runway for more than 3 years based on current free cash flow.

CYBERDYNE has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -68.9% each year.


Next Steps

Dividend

What is CYBERDYNE's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate CYBERDYNE's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate CYBERDYNE's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as CYBERDYNE has not reported any payouts.

Unable to verify if CYBERDYNE's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as CYBERDYNE has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of CYBERDYNE's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of CYBERDYNE's salary, the management and board of directors tenure and is there insider trading?

10.6yrs

Average board tenure


CEO

Yoshiyuki Sankai (61yo)

13.6yrs

Tenure

0

Mr. Yoshiyuki Sankai has been the President and Chief Executive Officer of CYBERDYNE Inc. since February 2006 and also serves as its Chairman. Mr. Sankai established CYBERDYNE, Inc. in June 2004. He has be ...


Board Age and Tenure

10.6yrs

Average Tenure

59yo

Average Age

The average tenure for the CYBERDYNE board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Yoshiyuki Sankai (61yo)

    Chairman

    • Tenure: 13.6yrs
  • Fumiyuki Ichihashi (41yo)

    Team Leader of Information Strategy Team & Director

    • Tenure: 15.3yrs
  • Shinji Uga (49yo)

    Head of Corporate Unit & Director

    • Tenure: 10.6yrs

Board Members

  • Cees Vellekoop (63yo)

    Outside Audit & Supervisory Board Member

    • Tenure: 12.3yrs
  • Hikari Imai (70yo)

    Outside Director

    • Tenure: 4.3yrs
  • Kazumasa Yoshida (61yo)

    Outside Director

    • Tenure: 6.3yrs
  • Kenichiro Okamura (48yo)

    Outside Audit & Supervisory Board Member

    • Tenure: 8.3yrs
  • Yoshiyuki Sankai (61yo)

    Chairman

    • Tenure: 13.6yrs
  • Fumiyuki Ichihashi (41yo)

    Team Leader of Information Strategy Team & Director

    • Tenure: 15.3yrs
  • Shinji Uga (49yo)

    Head of Corporate Unit & Director

    • Tenure: 10.6yrs
  • Hiroaki Kawamoto (45yo)

    Director

    • Tenure: 15.3yrs
  • Kinichi Nakata (57yo)

    Outside Director

    • Tenure: 11.3yrs
  • Yutaka Fujitani (66yo)

    Outside Audit & Supervisory Board Member (Full-Time)

    • Tenure: 8.3yrs

Company Information

CYBERDYNE Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CYBERDYNE Inc.
  • Ticker: CYBQ.F
  • Exchange: OTCPK
  • Founded: 2004
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥142.208b
  • Listing Market Cap: JP¥1.316b
  • Shares outstanding: 215.14m
  • Website: https://www.cyberdyne.jp

Number of Employees


Location

  • CYBERDYNE Inc.
  • 2-2-1, Gakuen-Minami
  • Tsukuba
  • Ibaraki
  • 305-0818
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7779TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYMar 2014
8C4DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2014
CYBQ.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2014
CYBQ.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDOct 2015

Biography

CYBERDYNE Inc. manufactures and sells medical devices in Japan and internationally. The company offers Hybrid Assistive Limb (HAL) for medical use, living support, and care/labor support; HAL peripherals;  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:24
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.